Janus Kinase Inhibitors

JAK Inhibitors in Dermatology Patients With Skin of Color
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.
JDD April 2026 Highlights
Journal of Drugs in Dermatology April 2026 Issue Highlights Welcome to the April edition the JDD Highlights! Each month, we dive into the Journal of Drugs in Dermatology to bring you the most impactful research and clinical updates selected by the editor. This month’s selection reflects the rapidly evolving landscape of modern dermatology. From the diagnostic precision of Artificial Intelligence in nail disorders to the "cosmetic elegance" of seborrhe …
Journal of Drugs in Dermatology April 2026 Issue Highlights